Search Results - Noel Ellison

  • Showing 1 - 1 results of 1
Refine Results
  1. 1

    Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study by Rosario Pivonello, Irina Bancos, Richard A. Feelders, Atil Y. Kargi, Janice M. Kerr, Murray B. Gordon, Cary N. Mariash, Massimo Terzolo, Noel Ellison, Andreas G. Moraitis

    Published in Frontiers in Endocrinology (2021-07-01)
    Get full text
    Article


Search Tools: